About Mr Matthew Wakefield
Mr Matthew Wakefield a Consultant Eye Surgeon for Salisbury NHS Foundation Trust (SFT) and responsible for their award-winning cataract surgery service. He is an expert in micro-incision cataract surgery, as well as complex cataract surgery and provides lens replacement surgery to reduce dependence on glasses. Mr Wakefield is a Lead Trainer on the Royal College of Ophthalmologists’ Microsurgical Skills Faculty, teaching surgeons of the future how to perform cataract surgery.
Mr Wakefield is the former Lead Consultant Eye Surgeon for SFT and has developed into the role of Lead Ophthalmologist for the Bath and North East Somerset, Swindon and Wiltshire Together integrated care system (ICS) and is responsible for helping drive clinical efficiency and excellence in NHS Eye Care across the region.
Mr Wakefield graduated from the University of Birmingham and completed his post-graduate Ophthalmic Specialist Training in the UK. With his advanced specialist training in corneal and external eye disease, he also runs the SFT corneal surgery service, providing corneal graft surgery to patients across Wiltshire, Swindon and Dorset. He also previously served on the Royal College of Ophthalmologists’ Refractive Surgery Examinations Committee, helping to ensure National Standards for both NHS and Private Eye Surgery.
He has published his PhD thesis examining the functional properties of a group of molecules that protect the surface of the eye from dryness and has won international awards for his research on UK National outcomes of corneal graft surgery related to donor characteristics and the spectroscopic identification of micro-organisms causing corneal infection.
Mr Wakefield has been an invited speaker at prestigious scientific events, such as the Royal College of Ophthalmologists National Congress. He is a Fellow of The Royal College of Ophthalmologists and a member of The Bowman’s Club, European Society of Cataract and Refractive Surgeons and the Medical Contact Lens and Ocular Surface Association.